Press Resease

Pediatric Vaccine Market By Vaccine Type (Monovalent and Multivalent), By Administration Method (Oral, Intramuscular, and Subcutaneous), By Disease Type (Meningococcal Disease, Hepatitis, Influenza, Polio, Pneumococcal Disease, DTP, MMR, Dengue, Rotavirus, HPV, Varicella, Herpes Zoster, and Others), By Technology (Recombinant Vaccines, Inactivated Vaccines, Conjugate Vaccines, Toxoid Vaccines, and Live Attenuated Vaccines), and By End-User (Hospitals, Healthcare Providers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 09-Aug-2019 Category: Pharmaceutical Report Format : PDF Pages: 126 Report Code: ZMR-4574 Status : Published

Global pediatric vaccine market expected to generate around USD 56.28 billion by 2025, at a CAGR of around 10.8% between 2019 and 2025. Pediatric vaccines protect children from complications and serious illnesses, which could lead to paralysis, brain damage, amputations, and even death.

Description

The report analyzes and forecasts the pediatric vaccine market on a global and regional level. The study offers past data from 2016 to 2018 and a forecast from 2019 to 2025 based on revenue (USD Billion). The assessment of pediatric vaccine market gives a brief thought about the drivers and restraints of the pediatric vaccine market along with the impact they have on the demand over the years to come. Additionally, the report also includes the study of opportunities available in the pediatric vaccine market on a global level.

The report gives a transparent view of the pediatric vaccine market. We have included a detailed competitive scenario and portfolio of the leading vendors operating in the pediatric vaccine market. To understand the competitive landscape in the pediatric vaccine market, an analysis of Porter’s Five Forces model has also been included. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Pediatric Vaccine Market

The study provides a crucial view of the pediatric vaccine market by segmenting it based on the vaccine type, disease type, technology, administration method, end-user, and region. All the segments of the pediatric vaccine market have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment comprises the current and forecast demand for the Middle East and Africa, North America, Asia Pacific, Latin America, and Europe.

Some key players operating in the global pediatric vaccine market are Mitsubishi Tanabe Pharma, Astellas Pharma, Johnson & Johnson, Pfizer, CSL Limited, GlaxoSmithKline, Serum Institute of India, Panacea Biotec, Daiichi Sankyo, and Merck.

This report segment the global pediatric vaccine market into:

Global Pediatric Vaccine Market: By Vaccine Type

  • Monovalent Vaccines
  • Multivalent Vaccines

Global Pediatric Vaccine Market: By Disease Type

  • Meningococcal Disease
  • Hepatitis
  • Influenza
  • Polio
  • Pneumococcal Disease
  • DTP
  • MMR (Measles, Mumps, and Rubella)
  • Dengue
  • Rotavirus
  • Human Papilloma Virus (HPV)
  • Varicella
  • Herpes Zoster
  • Others

Global Pediatric Vaccine Market: By Technology

  • Recombinant Vaccines
  • Inactivated Vaccines
  • Conjugate Vaccines
  • Toxoid Vaccines
  • Live Attenuated Vaccines

Global Pediatric Vaccine Market: By Administration Method

  • Oral
  • Intramuscular
  • Subcutaneous

Global Pediatric Vaccine Market: By End-User

  • Hospitals
  • Healthcare Providers
  • Others

Global Pediatric Vaccine Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Pediatric Vaccine Market Revenue, 2016-2025 (USD Billion)
    • 2.2. Global Pediatric Vaccine Market: Snapshot
  •  
  • Chapter 3. Pediatric Vaccine- Market: Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Pediatric Vaccine Market Drivers: Impact Analysis
      • 3.2.2. The growing prevalence of infectious diseases
      • 3.2.3. The increasing disposable income
      • 3.2.4. Multiple immunization programs by governments
      • 3.2.5. Rising awareness about the importance of preventive care
    • 3.3. Market restraints
      • 3.3.1. High vaccine cost
    • 3.4. Opportunities
      • 3.4.1. Emerging Markets
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Vaccine Type
      • 3.6.2. Market attractiveness analysis, by Disease Type
      • 3.6.3. Market attractiveness analysis, by Administration Method
      • 3.6.4. Market attractiveness analysis, by Technology
      • 3.6.5. Market attractiveness analysis, by End-User
      • 3.6.6. Market attractiveness analysis, by Region
  •  
  • Chapter 4. Global Pediatric Vaccine Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Pediatric Vaccine Market: Company Market Share, 2018
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Applications Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
  •  
  • Chapter 5. Global Pediatric Vaccine Market - Vaccine Type Analysis
    • 5.1. Global Pediatric Vaccine Market: Vaccine Type overview
      • 5.1.1. Global Pediatric Vaccine Market share, by Vaccine Type, 2018 and 2025
    • 5.2. Monovalent vaccines
      • 5.2.1. Global Pediatric Vaccine Market for monovalent vaccines, 2016-2025 (USD Billion)
    • 5.3. Multivalent vaccines
      • 5.3.1. Global Pediatric Vaccine Market for multivalent vaccines, 2016-2025 (USD Billion)
  •  
  • Chapter 6. Global Pediatric Vaccine Market - Disease Type Analysis
    • 6.1. Global Pediatric Vaccine Market: Disease Type overview
      • 6.1.1. Global Pediatric Vaccine Market share, by Disease Type, 2018 and 2025
    • 6.2. Dengue
      • 6.2.1. Global Pediatric Vaccine Market for Dengue, 2016-2025 (USD Billion)
    • 6.3. Pneumococcal Disease
      • 6.3.1. Global Pediatric Vaccine Market for Pneumococcal Disease, 2016-2025 (USD Billion)
    • 6.4. Hepatitis
      • 6.4.1. Global Pediatric Vaccine Market for Hepatitis, 2016-2025 (USD Billion)
    • 6.5. MMR
      • 6.5.1. Global Pediatric Vaccine Market for MMR, 2016-2025 (USD Billion)
    • 6.6. Varicella
      • 6.6.1. Global Pediatric Vaccine Market for Varicella, 2016-2025 (USD Billion)
    • 6.7. Polio
      • 6.7.1. Global Pediatric Vaccine Market for Polio, 2016-2025 (USD Billion)
    • 6.8. Influenza
      • 6.8.1. Global Pediatric Vaccine Market for Influenza, 2016-2025 (USD Billion)
    • 6.9. DTP
      • 6.9.1. Global Pediatric Vaccine Market for DTP, 2016-2025 (USD Billion)
    • 6.10. Herpes Zoster
      • 6.10.1. Global Pediatric Vaccine Market for Herpes Zoster, 2016-2025 (USD Billion)
    • 6.11. Rotavirus
      • 6.11.1. Global Pediatric Vaccine Market for Rotavirus, 2016-2025 (USD Billion)
    • 6.12. Human Papilloma Virus (HPV)
      • 6.12.1. Global Pediatric Vaccine Market for Human Papilloma Virus (HPV), 2016-2025 (USD Billion)
    • 6.13. Meningococcal Disease
      • 6.13.1. Global Pediatric Vaccine Market for Meningococcal Disease, 2016-2025 (USD Billion)
    • 6.14. Others
      • 6.14.1. Global Pediatric Vaccine Market for Others, 2016-2025 (USD Billion)
  •  
  • Chapter 7. Global Pediatric Vaccine Market - Technology Analysis
    • 7.1. Global Pediatric Vaccine Market: Technology segment overview
      • 7.1.1. Global Pediatric Vaccine Market share, by Technology, 2018 and 2025
    • 7.2. Recombinant Vaccines
      • 7.2.1. Global Pediatric Vaccine Market for Recombinant Vaccines, 2016-2025 (USD Billion)
    • 7.3. Inactivated Vaccines
      • 7.3.1. Global Pediatric Vaccine Market for Inactivated Vaccines, 2016-2025 (USD Billion)
    • 7.4. Conjugate Vaccines
      • 7.4.1. Global Pediatric Vaccine Market for Conjugate Vaccines, 2016-2025 (USD Billion)
    • 7.5. Toxoid Vaccines
      • 7.5.1. Global Pediatric Vaccine Market for Toxoid Vaccines, 2016-2025 (USD Billion)
    • 7.6. Live Attenuated Vaccines
      • 7.6.1. Global Pediatric Vaccine Market for Live Attenuated Vaccines, 2016-2025 (USD Billion)
  •  
  • Chapter 8. Global Pediatric Vaccine Market - Administration Method Analysis
    • 8.1. Global Pediatric Vaccine Market: Administration Method overview
      • 8.1.1. Global Pediatric Vaccine Market share, by Administration Method, 2018 and 2025
    • 8.2. Oral
      • 8.2.1. Global Pediatric Vaccine Market for oral, 2016-2025 (USD Billion)
    • 8.3. Intramuscular
      • 8.3.1. Global Pediatric Vaccine Market for intramuscular, 2016-2025 (USD Billion)
    • 8.4. Subcutaneous
      • 8.4.1. Global Pediatric Vaccine Market for subcutaneous, 2016-2025 (USD Billion)
  •  
  • Chapter 9. Global Pediatric Vaccine Market - End-User Analysis
    • 9.1. Global Pediatric Vaccine Market: End-User overview
      • 9.1.1. Global Pediatric Vaccine Market share, by End-User, 2018 and 2025
    • 9.2. Hospitals
      • 9.2.1. Global Pediatric Vaccine Market for Hospitals, 2016-2025 (USD Billion)
    • 9.3. Healthcare Providers
      • 9.3.1. Global Pediatric Vaccine Market for Healthcare Providers, 2016-2025 (USD Billion)
    • 9.4. Others
      • 9.4.1. Global Pediatric Vaccine Market for Others, 2016-2025 (USD Billion)
  •  
  • Chapter 10. Global Pediatric Vaccine Market - Regional Analysis
    • 10.1. Global Pediatric Vaccine Market: Regional overview
      • 10.1.1. Global Pediatric Vaccine Market share, by region, 2018 and 2025
    • 10.2. North America
      • 10.2.1. North America Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
      • 10.2.2. North America Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
      • 10.2.3. North America Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
      • 10.2.4. North America Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
      • 10.2.5. North America Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 10.2.6. The U.S.
        • 10.2.6.1. The U.S. Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
        • 10.2.6.2. The U.S. Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
        • 10.2.6.3. The U.S. Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 10.2.6.4. The U.S. Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
        • 10.2.6.5. The U.S. Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 10.2.7. Rest of North America
        • 10.2.7.1. Rest of North America Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
        • 10.2.7.2. Rest of North America Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
        • 10.2.7.3. Rest of North America Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 10.2.7.4. Rest of North America Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
        • 10.2.7.5. Rest of North America Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
    • 10.3. Europe
      • 10.3.1. Europe Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
      • 10.3.2. Europe Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
      • 10.3.3. Europe Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
      • 10.3.4. Europe Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
      • 10.3.5. Europe Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 10.3.6. Germany
        • 10.3.6.1. Germany Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
        • 10.3.6.2. Germany Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
        • 10.3.6.3. Germany Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 10.3.6.4. Germany Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
        • 10.3.6.5. Germany Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 10.3.7. The U.K.
        • 10.3.7.1. U.K. Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
        • 10.3.7.2. U.K. Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
        • 10.3.7.3. U.K. Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 10.3.7.4. U.K. Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
        • 10.3.7.5. U.K. Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 10.3.8. France
        • 10.3.8.1. France Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
        • 10.3.8.2. France Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
        • 10.3.8.3. France Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 10.3.8.4. France Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
        • 10.3.8.5. France Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 10.3.9. Rest of Europe
        • 10.3.9.1. Rest of Europe Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
        • 10.3.9.2. Rest of Europe Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
        • 10.3.9.3. Rest of Europe Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 10.3.9.4. Rest of Europe Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
        • 10.3.9.5. Rest of Europe Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
    • 10.4. Asia Pacific
      • 10.4.1. Asia Pacific Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
      • 10.4.2. Asia Pacific Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
      • 10.4.3. Asia Pacific Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
      • 10.4.4. Asia Pacific Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
      • 10.4.5. Asia Pacific Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 10.4.6. China
        • 10.4.6.1. China Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
        • 10.4.6.2. China Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
        • 10.4.6.3. China Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 10.4.6.4. China Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
        • 10.4.6.5. China Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 10.4.7. Japan
        • 10.4.7.1. Japan Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
        • 10.4.7.2. Japan Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
        • 10.4.7.3. Japan Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 10.4.7.4. Japan Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
        • 10.4.7.5. Japan Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 10.4.8. India
        • 10.4.8.1. India Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
        • 10.4.8.2. India Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
        • 10.4.8.3. India Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 10.4.8.4. India Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
        • 10.4.8.5. India Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 10.4.9. Rest of Asia Pacific
        • 10.4.9.1. Rest of Asia Pacific Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
        • 10.4.9.2. Rest of Asia Pacific Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
        • 10.4.9.3. Rest of Asia Pacific Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 10.4.9.4. Rest of Asia Pacific Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
        • 10.4.9.5. Rest of Asia Pacific Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
    • 10.5. Latin America
      • 10.5.1. Latin America Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
      • 10.5.2. Latin America Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
      • 10.5.3. Latin America Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
      • 10.5.4. Latin America Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
      • 10.5.5. Latin America Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 10.5.6. Brazil
        • 10.5.6.1. Brazil Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
        • 10.5.6.2. Brazil Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
        • 10.5.6.3. Brazil Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 10.5.6.4. Brazil Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
        • 10.5.6.5. Brazil Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
      • 10.5.7. Rest of Latin America
        • 10.5.7.1.
        • Rest of Latin America Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
        • 10.5.7.2. Rest of Latin America Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
        • 10.5.7.3. Rest of Latin America Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
        • 10.5.7.4. Rest of Latin America Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
        • 10.5.7.5. R
        • est of Latin America Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
    • 10.6. The Middle East and Africa
      • 10.6.1. The Middle East and Africa Pediatric Vaccine Market Revenue, by Vaccine Type, 2016-2025 (USD Billion)
      • 10.6.2. The Middle East and Africa Pediatric Vaccine Market Revenue, by Disease Type, 2016-2025 (USD Billion)
      • 10.6.3. The Middle East and Africa Pediatric Vaccine Market Revenue, by Technology, 2016-2025 (USD Billion)
      • 10.6.4. The Middle East and Africa Pediatric Vaccine Market Revenue, by Administration Method, 2016-2025 (USD Billion)
      • 10.6.5. The Middle East and Africa Pediatric Vaccine Market Revenue, by End-User, 2016-2025 (USD Billion)
  •  
  • Chapter 11. Company Profile
    • 11.1. Mitsubishi Tanabe Pharma
      • 11.1.1. Overview
      • 11.1.2. Financials
      • 11.1.3. Therapy portfolio
      • 11.1.4. Business strategy
      • 11.1.5. Recent developments
    • 11.2. Astellas Pharma
      • 11.2.1. Overview
      • 11.2.2. Financials
      • 11.2.3. Therapy portfolio
      • 11.2.4. Business strategy
      • 11.2.5. Recent developments
    • 11.3. Johnson & Johnson
      • 11.3.1. Overview
      • 11.3.2. Financials
      • 11.3.3. Therapy portfolio
      • 11.3.4. Business strategy
      • 11.3.5. Recent developments
    • 11.4. Pfizer
      • 11.4.1. Overview
      • 11.4.2. Financials
      • 11.4.3. Therapy portfolio
      • 11.4.4. Business strategy
      • 11.4.5. Recent developments
    • 11.5. CSL Limited
      • 11.5.1. Overview
      • 11.5.2. Financials
      • 11.5.3. Therapy portfolio
      • 11.5.4. Business strategy
      • 11.5.5. Recent developments
    • 11.6. GlaxoSmithKline
      • 11.6.1. Overview
      • 11.6.2. Financials
      • 11.6.3. Therapy portfolio
      • 11.6.4. Business strategy
      • 11.6.5. Recent developments
    • 11.7. Serum Institute of India
      • 11.7.1. Overview
      • 11.7.2. Financials
      • 11.7.3. Therapy portfolio
      • 11.7.4. Business strategy
      • 11.7.5. Recent developments
    • 11.8. Panacea Biotec
      • 11.8.1. Overview
      • 11.8.2. Financials
      • 11.8.3. Therapy portfolio
      • 11.8.4. Business strategy
      • 11.8.5. Recent developments
    • 11.9. Daiichi Sankyo
      • 11.9.1. Overview
      • 11.9.2. Financials
      • 11.9.3. Therapy portfolio
      • 11.9.4. Business strategy
      • 11.9.5. Recent developments
    • 11.10. Merck
      • 11.10.1. Overview
      • 11.10.2. Financials
      • 11.10.3. Therapy portfolio
      • 11.10.4. Business strategy
      • 11.10.5. Recent developments

Methodology

Free Analysis

Vaccines provide protection against various diseases in the form of toxins or proteins. Vaccines are responsible for improving one’s immunity. Immunization is vital for the global health market and is an essential part of medicine. There are several immunization programs for children organized across several nations, but they may vary depending on the region. For instance, developed countries have specific primary immunization schedules. These immunizations schedules based on a child’s health, vaccine type, geographical area, and the vaccines available in that area. Vaccines are administered for different types of diseases like Hepatitis B, tetanus, influenza, chickenpox, measles, mumps, etc. These schedules are recommended by various agencies, such as the CDC, American Academy of Family Physicians, and the American Academy of Pediatrics. When weakened disease germs in the vaccine attack the immune system, the immune system sends antibodies to fight these germs and prevents the system from acquiring the disease if exposed to it in the future.

The global pediatric vaccine market is driven by increasing geriatric base, rising prevalence of infectious diseases, and growing disposable income of the global population. The rising number of immunization programs globally and the increasing awareness about the importance of preventive care during childhood are also fuelling this market. Various governments are taking initiative to increase the importance of vaccine development and leading companies are sponsoring R&D programs to enhance vaccine development for rare diseases. For example, government initiatives like the Vaccines for Children Program organize vaccination drives for children who cannot afford vaccines or do not have health insurance. However, the high vaccine cost may restrain the market growth in the future.

Global Pediatric Vaccine Market

The global pediatric vaccine market is divided based on disease type, vaccine type, administration method, technology, and end-user. By vaccine type, the market includes monovalent and multivalent vaccines. Monovalent vaccines develop a rapid immune response and are more stable than multivalent vaccines. Multivalent vaccines are showing improved growth due to the development of tetravalent, hexavalent, and pentavalent vaccines. Based on technology,  the market comprises recombinant vaccines, inactivated vaccines, conjugate vaccines, toxoid vaccines, and live attenuated vaccines. Conjugate vaccines have the maximum demand, due to the rising incidences of meningococcal and pneumococcal infections. The disease type segment consists of dengue, pneumococcal disease, hepatitis, MMR (measles, mumps, and rubella), varicella, polio, influenza, DTP, herpes zoster, rotavirus, human papilloma virus, meningococcal disease, and others. The method segment of the pediatric vaccine market includes oral, subcutaneous, and intramuscular. Hospitals, healthcare providers, and others are the various end-user of the pediatric vaccine market.

North America is witnessed to be a significant contributor to the pediatric vaccine market globally, due to the increasing number of hospitals, developing insurance sector, and favorable government regulations. The European pediatric vaccine market is growing owing to the ease of operability, efficient resource planning, presence of a large number of pharmaceutical companies, and rising government funding. All this makes facilitates quick and easy sourcing of vaccines. The Asia Pacific pediatric vaccine market will register the highest CAGR in the future, owing to the rapidly growing pediatric vaccine demand in India and Singapore.

Some key players operating in the global pediatric vaccine market are Mitsubishi Tanabe Pharma, Astellas Pharma, Johnson & Johnson, Pfizer, CSL Limited, GlaxoSmithKline, Serum Institute of India, Panacea Biotec, Daiichi Sankyo, and Merck. 

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com